🇺🇸 FDA
Pipeline program

Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor

460501

Phase 1 mab completed

Quick answer

Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor for Alpha 1-Antitrypsin Deficiency is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Alpha 1-Antitrypsin Deficiency
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials